Economic portfolio
ICICI Prudential Nifty Pharma Index Fund
ICICI ICICI Prudential Mutual Fund Jul 2026 — Sep 2026 3 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
3 priced months, Jul 2026 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
78.2% now · highest 79.1%, lowest 78.2%
Companies held
20 now · largest single holding 19.5% of equity
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Nippon India Nifty Pharma ETFNippon India · 20 shared100.0%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 16 shared81.1%
- DSP Nifty Healthcare ETFDSP · 16 shared81.1%
- Axis NIFTY Healthcare ETFAxis · 16 shared81.1%
- DSP Nifty Healthcare Index FundDSP · 16 shared81.1%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 16 shared81.1%
- EODWHFEdelweiss · 17 shared77.4%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared69.0%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- None this month.
Complete exits
- None this month.
Largest increases
- 01 Sun Pharmaceutical Industries Limited+6.7% +10,976
- 02 Dr. Reddy's Laboratories Limited+6.7% +6,371
- 03 Piramal Pharma Limited+6.6% +6,324
- 04 Cipla Limited+6.7% +5,853
- 05 Biocon Limited+4.2% +4,670
- 06 Laurus Labs Limited+6.8% +4,108
- 07 Aurobindo Pharma Limited+6.5% +2,807
- 08 Lupin Limited+6.7% +2,534
- 09 Zydus Lifesciences Limited+5.7% +2,207
- 10 Torrent Pharmaceuticals Limited+7.1% +1,608
Largest reductions
- None this month.
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 19.51% | 31.81 Cr | 0.02 Cr | by Jul 2026 (3 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 11.98% | 19.52 Cr | 21,013 | by Jul 2026 (3 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 7.82% | 12.75 Cr | 64,400 | by Jul 2026 (3 mo+) |
| Cipla Limited | Healthcare | Large Cap | 7.68% | 12.52 Cr | 93,053 | by Jul 2026 (3 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 7.63% | 12.43 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 7.17% | 11.68 Cr | 24,332 | by Jul 2026 (3 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 5.00% | 8.15 Cr | 40,165 | by Jul 2026 (3 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.69% | 7.64 Cr | 45,698 | by Jul 2026 (3 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.57% | 5.81 Cr | 24,895 | by Jul 2026 (3 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 3.16% | 5.15 Cr | 9,970 | by Jul 2026 (3 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.92% | 4.76 Cr | 40,975 | by Jul 2026 (3 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.88% | 4.69 Cr | 18,737 | by Jul 2026 (3 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.72% | 4.43 Cr | 22,971 | by Jul 2026 (3 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.62% | 4.27 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.34% | 3.82 Cr | 13,178 | by Jul 2026 (3 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 2.14% | 3.49 Cr | 22,870 | by Jul 2026 (3 mo+) |
| Wockhardt Limited | Healthcare | Small Cap | 1.77% | 2.89 Cr | 13,659 | by Jul 2026 (3 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.67% | 2.73 Cr | 7,537 | by Jul 2026 (3 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 1.43% | 2.34 Cr | 861 | by Jul 2026 (3 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 1.30% | 2.12 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
Half of its current holdings have been held for 3 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +10,976 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +6,371 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +6,324 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +5,853 |
| Biocon Limited | Sep 2026 | ▲ Increasing | +4,670 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +4,108 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +2,807 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +2,534 |
| Zydus Lifesciences Limited | Sep 2026 | ▲ Increasing | +2,207 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +1,608 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +1,570 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +1,496 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +1,453 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +1,325 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +1,203 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +1,021 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +914 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +871 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +837 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +66 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +5,542 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +3,734 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +3,253 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +3,189 |
| Cipla Limited | Aug 2026 | ▲ Increasing | +2,941 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +2,031 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +1,444 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +1,306 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +1,267 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +781 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +762 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +720 |
| Sai Life Sciences Limited | Aug 2026 | ▲ Increasing | +716 |
| Divi's Laboratories Limited | Aug 2026 | ▲ Increasing | +661 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +584 |
| Wockhardt Limited | Aug 2026 | ▲ Increasing | +426 |
| Gland Pharma Limited | Aug 2026 | ▲ Increasing | +414 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +297 |
| Ajanta Pharma Limited | Aug 2026 | ▲ Increasing | +214 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +18 |
Changes compare consecutive month-end disclosures for this portfolio only.